Feasibility of a family-oriented mHealth intervention for Chinese Americans with type 2 diabetes: A pilot randomized control trial
- PMID: 38466714
- PMCID: PMC10927140
- DOI: 10.1371/journal.pone.0299799
Feasibility of a family-oriented mHealth intervention for Chinese Americans with type 2 diabetes: A pilot randomized control trial
Abstract
Objectives: To test the feasibility, acceptability, and potential efficacy of a mHealth intervention tailored for Chinese immigrant families with type 2 diabetes (T2D).
Methods: We conducted a pilot randomized controlled trial (RCT) with baseline, 3-, and 6-month measurements. Participating dyads, T2D patients and families/friends from NYC, were randomized into the intervention group (n = 11) or the wait-list control group (n = 12). Intervention includes 24 videos covering T2D self-management, behavioral techniques, and family-oriented sessions. Feasibility and acceptability were measured respectively by the retention rate and video watch rate, and a satisfaction survey. Patients' HbA1c, weight, and self-management were also assessed to test potential efficacy.
Results: Most T2D patients (n = 23; mean age 56.2±9.4 years; 52.2% male) and families/friends (n = 23, mean age 54.6±11.2 years; 52.2% female) had high school education or less (69.6% and 69.6%), annual household income < $25,000 (65.2% and 52.2%), and limited English proficiency (95.7% and 95.7%). The retention rates were not significantly different between the intervention and the control groups for both the patients (90.91% vs 83.3%, p = 0.589); and their families/friends (3-month: 90.9% vs 75%, p = 0.313; 6-month: 90.9% vs 83.3%, p = 0.589). The mean video watch rate was 76.8% (7%). T2D patients and families/friends rated satisfaction as 9.4 and 10 out of 10, respectively. Despite no between-group differences, the intervention group had significantly lower HbA1c (p = 0.014) and better self-management (p = 0.009), and lost 12 lbs. on average at 6 months (p = 0.079), compared to their baseline levels.
Conclusions: A culturally-tailored, family-based mHealth intervention is feasible and acceptable among low-income, limited English-proficient Chinese families with T2D in NYC. Significant changes in HbA1c and self-management within the intervention group indicate this intervention may have potential efficacy. Given the small sample size of this study, a future RCT with adequate power is needed to test efficacy.
Copyright: © 2024 Hu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
LH reports holding stock in Tencent Holdings Limited. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Similar articles
-
Culturally Tailored Social Media Intervention Improves Health Outcomes in Chinese Americans with Type 2 Diabetes: Preliminary Evidence from a Pilot RCT.J Gen Intern Med. 2025 Jul;40(10):2319-2329. doi: 10.1007/s11606-025-09430-9. Epub 2025 Feb 27. J Gen Intern Med. 2025. PMID: 40016380 Clinical Trial.
-
Efficacy of a Mobile Health-Based Behavioral Treatment for Lifestyle Modification in Type 2 Diabetes Self-Management: Greenhabit Randomized Controlled Trial.J Med Internet Res. 2025 Jan 22;27:e58319. doi: 10.2196/58319. J Med Internet Res. 2025. PMID: 39841995 Free PMC article. Clinical Trial.
-
Digital Storytelling Intervention for Hemoglobin A1c Control Among Hispanic Adults With Type 2 Diabetes: A Randomized Clinical Trial.JAMA Netw Open. 2024 Aug 1;7(8):e2424781. doi: 10.1001/jamanetworkopen.2024.24781. JAMA Netw Open. 2024. PMID: 39093566 Free PMC article. Clinical Trial.
-
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3. Syst Rev. 2024. PMID: 39593159 Free PMC article.
-
Transition of care for adolescents from paediatric services to adult health services.Cochrane Database Syst Rev. 2016 Apr 29;4(4):CD009794. doi: 10.1002/14651858.CD009794.pub2. Cochrane Database Syst Rev. 2016. PMID: 27128768 Free PMC article.
Cited by
-
Characterizing Mental Health Status and Service Utilization in Chinese Americans With Type 2 Diabetes in New York City: Cross-Sectional Study.JMIR Form Res. 2024 Jul 2;8:e59121. doi: 10.2196/59121. JMIR Form Res. 2024. PMID: 38954806 Free PMC article.
-
Co-Designed Mobile-Based Cognitive Training for Older Chinese Americans: Protocol for a Pilot Randomized Controlled Trial Assessing Feasibility and Acceptability.JMIR Res Protoc. 2025 Jul 21;14:e69303. doi: 10.2196/69303. JMIR Res Protoc. 2025. PMID: 40690756 Free PMC article.
-
Diabetes Distress and Associated Factors Among Chinese Americans with Type 2 Diabetes in New York City.Diabetes Metab Syndr Obes. 2024 Jul 29;17:2845-2853. doi: 10.2147/DMSO.S459478. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 39100965 Free PMC article.
-
Understanding Mental Health Service Perceptions in Chinese Americans with Type 2 Diabetes and Co-Occurring Mental Health Challenges Living in New York City: A Qualitative Study.Diabetes Metab Syndr Obes. 2025 Jul 25;18:2525-2536. doi: 10.2147/DMSO.S529615. eCollection 2025. Diabetes Metab Syndr Obes. 2025. PMID: 40734941 Free PMC article.
References
-
- US Census Bureau. Chinese, Except Taiwanese, Was The Largest Asian Alone or in Any Combination Group; Nepalese Population Grew Fastest. 2023. Sep. Available: https://www.census.gov/library/stories/2023/09/2020-census-dhc-a-asian-p....
-
- Vicks WS, Lo JC, Guo L, Rana JS, Zhang S, Ramalingam ND, et al.. Prevalence of prediabetes and diabetes vary by ethnicity among U.S. Asian adults at healthy weight, overweight, and obesity ranges: an electronic health record study. BMC Public Health. 2022;22: 1954. doi: 10.1186/s12889-022-14362-8 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UL1 TR001445/TR/NCATS NIH HHS/United States
- P50 MD017356/MD/NIMHD NIH HHS/United States
- R25 HL105444/HL/NHLBI NIH HHS/United States
- R00 MD012811/MD/NIMHD NIH HHS/United States
- R01 MD017579/MD/NIMHD NIH HHS/United States
- U54 MD000538/MD/NIMHD NIH HHS/United States
- P30 DK111022/DK/NIDDK NIH HHS/United States
- K99 MD012811/MD/NIMHD NIH HHS/United States
- UG3 HL151310/HL/NHLBI NIH HHS/United States
- U48 DP006778/DP/NCCDPHP CDC HHS/United States
- R18 DK110740/DK/NIDDK NIH HHS/United States
- R01 DK110048/DK/NIDDK NIH HHS/United States
- R18 HS029813/HS/AHRQ HHS/United States
LinkOut - more resources
Full Text Sources
Medical